Steve Wagner

Steve Wagner currently serves as a Senior Project Manager at ICON plc, a position held since March 2023, focused on managing clinical trials. Previously, Steve worked as a Principal Investigator at Eurofins from March 2021 to March 2023 and as a Senior Scientist at OpenCell Technologies, Inc., where contributions included developing a novel transfection system enhancing transfection efficiency and cell viability. Steve's earlier experience includes roles as a Senior Scientist at Kypha, Inc., and as Lab Operations Lead/Molecular Biologist at Newsham Choice Genetics, managing large sample banks and overseeing molecular biology projects. At Monsanto, Steve held multiple positions, including Molecular Biologist and Staff Scientist, where key achievements involved RNA extractions and implementing SNP genotyping technologies. The career began as a research assistant at Washington University School of Medicine. Steve holds a degree from Saint Louis University, earned between 1989 and 1994.